Fusion protein of ganoderma lucidum immunoregulatory protein and human serum albumin, and production method therefor and uses thereof

摘要

The present invention relates to the field of biological pharmacy, and discloses a fusion protein rLZ-8-HAS of ganoderma lucidum immunoregulatory protein and human serum albumin that is produced by using a genetic engineering technology, and a production method therefor and uses thereof. Compared with rLZ-8, the fusion protein prolongs an in-vivo half-life period and improves the biological activity, and can be used as drugs for treating leucopenia and tumors.